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Background: Angiographically detected edge dissections increase the risk of early
stent thrombosis (ST). OCT detects an increased number of edge dissections. The
clinical implication of these findings and their natural history remain unclear.
Methods: Edge dissections were defined as disruptions of the luminal surface in the
5 mm segments proximal and distal to the stent. Quantitative and qualitative OCT
analyses were performed every 0.5 mm at baseline and 12 months, and clinical
outcomes were assessed.
Results: Twenty edge dissections in 18 patients were studied; none were
angiographically visible. Median longitudinal dissection length was 2.9 (interquart
range (IQR) 1.6-4.3) mm. Eighteen (90%) dissections exhibited flaps with a median
maximum length of 1.27 (IQR 0.88-1.67) mm. Cavities and false lumina were visible
in 7 (35%) dissections with a median maximum width of 0.97 (IQR 0.87-1.25) and
1.62 (1.30-2.20) mm, respectively. Dissections extended into the media in 10 (50%)
cases and involved 2 quadrants in 4 (20%) cases. Sixteen of 20 dissections were
evaluated with IVUS which identified 8 of 16 OCT detected dissections. No ST or
target lesion revascularisation occurred up to 12 months. At follow-up, 90% of
dissections were completely healed (Fig A-C). The two cases showing signs of previous
dissection exhibited the longest flap (2.33 mm) and thickest false lumen cap (1.09 mm)
in the cohort, and both extended ≥4.3mm longitudinally.
Conclusion: OCT defined edge dissections appeared to be healed at 12 months with
no adverse clinical events. A cautious approach to the treatment of OCT defined edge
dissections should be considered.
TCT-660
In Vivo Findings of Tissue Characteristics in High-Risk Coronary Artery
Plaques Using iMapTM IVUS
Karlis Trusinskis, Dace Juhnevica, Karlis Strenge, Dace Sondore, Indulis Kumsars,
Inga Narbute, Sanda Jegere, Andrejs Erglis
Pauls Stradins Clinical University Hospital, Riga, Latvia
Background: The rationale of atherosclerosis imaging is identification of high-risk
lesions, which may subsequentely lead to prevention of future cardiovascular events.
iMapTM tissue characterisation analysis is a novel technology which allows
identification of atherosclerotic plaque components (necrotic, fibrotic, lipidic tissue
and calcium) with certain degree of confidence, exclude from analysis echo negative
areas, such as areas masked behind calcified tissue that could be mistaken by automatic
analysis for necrotic tissue.The aim of the study was to investigate composition of
ruptured atherosclerotic plaque by iMap tissue characterisation in patients with ST
segment elevation myocardial infarction (STEMI).
Methods: 77 STEMI patients with TIMI 2-3 flow after thrombosuction in culprit artery
were included and IVUS Tissue Characterisation (iMap, IVUS, Boston Scientific
Corp., Minneapolis, MN, USA) were done. Clinical and angiographic follow-up with
IVUS for culprit vessel was performed after 296±48 days. IVUS catheter was advanced
10mm beyond the culprit lesion or stent at follow-up and was pulled back to a point of
20mm proximal to the lesion or stent at follow-up.
Results: Tissue Characterization showed high percentage of necrotic tissue in culprit
lesion and also in proximal segment of it (23.84 ± 11.19 and 22.73 ± 11.97,
respectively). At the follow-up we observed less percentage of necrotic core
(17.08±7.16 vs 22.73±21.46, p=0.003), and more percentage of fibrotic tissue
(70.22±9.94 vs 53.01±14.67, p=0.002) at the proximal segment when compared with
the index procedure. No restenosis or reocclusion of proximal segment at 10 month
follow-up were found.
Conclusion: Our study showed significant proportion of necrotic tissue in culprit
segment and 20mm proximal to culprit lesion as well as plaque stabilization in STEMI
patients by tissue characterisation analyses at 10 months follow-up. However, high
amount of necrotic tissue in proximal segment of the culprit lesion left uncovered by
stent were not associated with restenosis or reocclusion.
TCT-661
Relation Between Poststenting Peristent Plaque Components and Late
Acquired Drug-Eluting Stent Malapposition: Virtual Histology-Intravascular
Ultrasound Analysis
Young Joon Hong1, Myung Ho Jeong1, Seung Uk Lee2, Yun Ha Choi1, Jin A Song1,
Dong Han Kim1, Ki Hong Lee1, Min Goo Lee1, Keun Ho Park1, Doo Sun Sim1, Ju
Han Kim1, Youngkeun Ahn1, Jeong Gwan Cho1, Jung Chaee Kang1
1Chonnam National University Hospital, Gwangju, Republic of Korea; 2Kwang Ju
Christian Hospital, Gwangju, Republic of Korea
Background: Impact of plaque composition on late acquired stent malapposition
(LSM) after drug-eluting stent (DES) implantation has not been evaluated.
Methods: We evaluated the relation between plaque components at poststenting
peristent area (between external elastic membrane and stent areas) and LSM after DES
implantation in 266 patients (314 native lesions; paclitaxel-eluting stent in 205 lesions,
sirolimus-eluting stent in 66 lesions, zotarolimus-eluting stent in 32 lesions and
everolimus-eluting stent in 11 lesions) in whom virtual-histology intravascular
ultrasound was performed at index and 12-month follow-up.
Results: LSM occurred in 24 patients with 30 lesions (10%) and there was no
significant difference in the incidence of LSM among 4 stent groups [21/205 (10%) in
paclitaxel-eluting stent, 4/34 (12%) in sirolimus-eluting stent, 6/66 (9%) in
zotarolimus-eluting stent and 1/11 (9%) in everolimus-eluting stent, P=0.5). Patients
with LSM were presented with more acute myocardial infarction (50% vs 28%,
P=0.026) and were more diabetics (50% vs 30%, P=0.030) and used multiple stents
(40% vs 16%, P=0.001) and overlapping stents (40% vs 14%, P<0.001) more
frequently compared with those without LSM. Lesions with LSM had more persistent
%necrotic core (NC) volumes compared with those without LSM (25.8±11.1% vs.
21.0±5.7%, P<0.001). Malapposition volume correlated with peristent %NC volume
(R=0.489, P=0.009) and peristent %FT volume (R=-0.472, P=0.006). Independent
predictors of LSM at 12-month follow-up were poststenting peristent %NC volume
[odds ratio (OR); 1.216, 95% CI; 1.053-1.405, P=0.008], acute myocardial infarction
(OR; 2.897, 95% CI; 1.675-4.118, P=0.029), and diabetes mellitus (OR; 2.413, 95%
CI; 1.543-3.996, P=0.038).
Conclusion: Poststenting persistent NC components, myocardial infarction, and
diabetes mellitus were associated with the development of LSM after DES
implantation.
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Impact of Post-Interventional Minimal Stent Area on Angiographic Restenosis
after Zotarolimus and Everolimus-Eluting Stent implantation
Hae-Geun Song, Soo-Jin Kang, Kyung-Min Park, Jung-Min Ahn, Duk-Woo Park,
Jong-Young Lee, Won-Jang Kim, Seung-Whan Lee, Young-Hak Kim, Cheol Whan
Lee, Seong-Wook Park, Seung-Jung Park
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Background: Stent underexpansion is a strong predictor of restenosis after bare-metal
stent and first-generation drug-eluting stent implantation. However, the implication of
underexpansion in Zotarolimus-eluting stent(ZES) and Everolimus-eluting stent(EES)
has not been addressed yet
Methods: Angiographic and intravascular ultrasound(IVUS) data immediately after
stenting and at 9-month follow-up were available in 912 patients with 990 lesions: 541
sirolimus-eluting stent(SES), 220 ZES, 229 EES. The minimal stent area(MSA)
predicts angiographic in-stent restenosis(ISR) was determined.
Results: The post-procedural IVUS MSA was 6.4±1.8 mm2, 6.2±2.1 mm2, 6.2±2.1
mm2 in SES, ZES, EES group. At 9-months follow-up, ISR was similar in SES, ZES
and EES group. (3.3%, 4.5%, 4.4%, p=0.53) Using multivariable logistic regression
analysis, the only independent predictor of ISR in each stent group was post-
interventional IVUS MSA. (p<0.001 for SES, p=0.003 for ZES and p=0.015 for ZES).
Using receiver operating characteristic analysis, post-interventional IVUS MSA was
shown as faithful discriminator between ISR and non-ISR(c=0.739 for SES, c=0.672
for ZES and c=0.639 for EES). The optimal cut-off value of post-interventional IVUS
MSA predict stent patency at 9 months were 5.5 mm2 for SES, 5.3 mm2 for ZES and
5.4 mm2 for EES.
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Figure. Optimal Minimal Stent Area in SES,ZES and EES
Conclusion: Post-interventional IVUS MSA is also a strong predictor of restenosis
after second-generation drug-eluting stent implantation.
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Background: We studied angiographic, grayscale and radiofrequency (RF) IVUS
characteristics of untreated nonculprit lesions in pts with diabetes (DM) and/or
metabolic syndrome (MS) from the PROSPECT trial.
Methods: In PROSPECT, pts with acute coronary syndromes (ACS) underwent 3-
vessel quantitative coronary angiography, grayscale, and RF-IVUS after successful
culprit lesion stenting. Recurrent MACE (cardiac death/arrest, myocardial infarction
or rehospitalization for angina) were adjudicated to originally treated culprit vs.
untreated nonculprit lesions in pts with DM, MS or no DM.
Results: Among 673 pts with available cardiometabolic status, 119 (17.6%) had DM
and 239 (35.5%) had MS. The 3-year cumulative MACE rate was 29.4% in DM pts,
21.3% in MS and 17.4% in no DM or MS pts (p=0.03). MACE was adjudicated to
nonculprit lesions in 18.7%, 11.7% and 9.7% of pts, respectively (p=0.06). In
nonculprit MACE lesions, grayscale IVUS measures of plaque burden and minimal
luminal area (MLA) were similar in the 3 groups. However, lesions of pts with DM
compared to those from MS and no DM pts had significantly greater necrotic core
(0.71 ± 0.49 vs 0.61 ± 0.54 and 0.55 ± 0.59 mm2 respectively, p=0.01) and calcified
plaque area (0.41 ± 0.38 vs 0.31 ± 0.38 and 0.29 ± 0.37 mm2 respectively, p=0.004).
DM patients also had more nonculprit lesions containing >2 high risk plaque features
(plaque burden ≥70%, MLA ≤4 mm2 and/or thin cap fibroatheroma) (51.3% vs 45.9%
vs 39.5% respectively, p=0.03).
Conclusion: During 3-year follow-up after PCI of all culprit lesions in ACS, MACE
due to untreated nonculprit lesions was significantly increased in pts with vs without
DM. Although DM and no-DM nonculprit lesions had similar measures of plaque
burden and MLA, they contained significantly greater necrotic core, likely contributing
to the increased event rate.
TCT-664
SYNTAX Score Reflects Coronary Plaque Characteristics Assessed By
Integrated Backscatter Intravascular Ultrasound
Hideaki Ota, Junko Honye, Munenori Okubo, Hiroki Kondo, Taiji Miyake, Shigeshi
Kamikawa, Yoshiaki Kawase, Kunihiko Tsuchiya, Hitoshi Matsuo, Katsumi Ueno
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Background: It has been proven that some coronary risk factors have influence on
coronary plaque characteristics assessed by intravascular ultrasound (IVUS). However,
the relationship between components and complexity of coronary lesions has not been
shown. To elucidate the relationship between components of coronary plaques assessed
by integrated backscatter IVUS (IB-IVUS) and complexity of coronary lesions
quantified by SYNTAX score.
Methods: A total of 85 de novo lesions in 73 patients were classified based on
SYNTAX score: low (1 to 7: n=29), medium (8 to 11: n=31), and high score group (12
to 20: n=25). Tissue characteristics of the plaque in the culprit lesion were analyzed
using IB-IVUS and classified into four categories: calcified, dense-fibrotic, fibrotic,
and lipidic.
Results: There were no significant differences in baseline characteristics including
coronary risk factors, vessel area, and total plaque volume of the lesions among three
groups. Calcified, dense-fibrotic, and fibrotic components were significantly larger,
and lipidic component was significantly smaller in the high score group than those of
the low and medium score groups, except the fibrotic component between high and
medium score group (Table).
Table:
‡‡: p<0.01 vs. high score group
‡: p<0.05 vs. high score group
§: p=0.055 vs. high score group
Conclusion: The strong relationship between complexity of the lesions quantified by
SYNTAX score and plaque components analyzed by IB-IVUS was demonstrated. The
higher SYNTAX score, the more fibrosis and calcification were found in the plaque.
These results suggest that it is necessary to care about under-expansion due to hard
plaque in the high SYNTAX score and distal embolization due to high lipid contents
within the plaques in lower SYNTAX score.
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Association between Novel Three-Dimensional Geometrical Lesion Analysis and
Indicators of Plaque Vulnerability
Danny Dvir1, Ifat Lavi1, Shmuel Einav2, Ran Kornowski1
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Background: Vascular geometry mediates fluid dynamics and shear stress and may
thereby predispose coronary arteries to atherosclerosis. However, the association
between three-dimensional (3D) vascular geometrical features in space and
vulnerability to plaque rupture, has not been investigated.
Methods: We evaluated 32 de novo coronary lesions by 3D coronary angiography
(CardiOp-B system, Paieon Inc). For geometrical analysis we developed a novel
algorithm that enables quantitative point evaluation of several geometrical features
along a vessel segment: defined mathematically by curvature and torsion, in numerous
points along the vessel path, and by the level of segment tortuosity. These parameters
describe the geometrical path in space and do not depend on the evaluated segment
projection. Segments were further evaluated by IVUS-VH (Volcano Corp.). For each
segment we collected data on 4 slices: proximal reference, distal reference, minimal
lesion area slice, and maximal necrotic core slice. On each slice we performed a
conventional IVUS examination that characterized the lesion parameters and performed
VH evaluation with calculation of the area and relative size of different plaque
components: fibrotic (F), fibrofatty (FF), DC, NC, NC/DC.
Results: We evaluated a total length of 633.97mm segments and performed
geometrical analysis on 4,403 points (6.9 points on average per 1mm segment). We
performed VH evaluation on 1,268 slices with a total vessel volume of 12,170 cc3.
Several geometrical measures were significantly correlated with IVUS-VH indicators
of plaque vulnerability as measured by sectional necrotic-core to dense-calcium ratio:
mean and max. lesion curvature (R=0.56, p=0.0008; R=0.61, p=0.0004); lesion
tortuosity (R=0.44, p= 0.011).
Conclusion: Coronary lesion tortuosity and curvature are significantly correlated with
indicators of plaque vulnerability. These data provide new insight into the role of 3D
vascular geometry in determining plaque instability.
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